FAQ| NEWLY DIAGNOSED | SYMPTOMS | CHAT ROOM & message BOARDS| in memory of Janis

JANIS AND FRIENDS HEPATITIS C WEB SITE

latest news

INTERNET CONFERENCES

WHATS NEW AT J&F

page updates

VX950-TELAPREVIR

other HCV Information

HISTORY OF HCV

GLOSSARY/ABBREVIATIONS

LIVER FUNCTIONS

QUESTIONS ABOUT HCV

EXTRAHEPATIC CONDITIONS

TRANSMISSION

SEXUAL TRANSMISSION

HCV BLOOD TESTS/LABS

LABS ON TREATMENT

BIOPSY RESULTS

ALTERNATIVE TO BIOPSY

STILL NEED A BIOPSY ?

ON BIOPSY WHAT DOES THE STAGE MEAN AND WHAT DOES THE GRADE ME ?

STAGES/LIVER DISEASE

TRANSPLANTS

LIVER CANCER

PEGASYS/ PEGINTRON

HELP/SIDE EFFECTS

DRUG INTERACTIONS

NUTRITION & HCV

TREATMENT STORIES

FIND A DOCTOR

FINANCIAL AID/MED ETC

SUPPORT GROUPS/TRANSPLANTS

HCV SUPPORT GROUPS

PICTURES Of OUR FRIENDS

INFORMATIONAL LINKS

This Web Site is committed to the memory of Janis Morrow.

Human liver

Cirrhosis

2004-2001 Archives

Back to Main Cirrhosis Page

2008 Research 2007 Research

2006 Research 2005 Research

2004-2001 Research Archives

Dec 2004

Page Twenty-Two

Treatment for Decompensated Cirrhotics

Dec 10 2004

Treatment for Compensated Cirrhotics

Dec 10 2004

Treatment for Relapsers and Non-Responders

Dec 09 2004

Persistent ascites and low serum sodium

Nov 28 2004

Late-Evening Snacks Containing Branched-Chain Amino Acids Benefit Hepatitis-Caused Cirrhosis

Page Twenty-One

Long-term Effect of Peginterferon Alfa-2b (Peg-Intron) Plus Ribavirin (Rebetol) on Incidence of Hepatocellular Carcinoma in Patients with HCV-related Cirrhosis

Nov 11 2004

Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) for the Treatment of Chronic HCV and Compensated Cirrhosis/Fibrosis

Nov 10 2004

Viremia, cirrhosis, and possibly knowledge of infection are associated with fatigue in HCV-infected VA patients

Page Twenty

Intercept Pharmaceuticals Announces Publication of Study Demonstrating Its Lead Compound Can Reverse Liver Fibrosis

Aug 11 2004

Nadolol in the prophylaxis of growth of small esophageal varices

Aug 11 2004

Role of Vitamin K2 in the Development of Hepatocellular Carcinoma in Women
With Viral Cirrhosis of the Liver

July 19 2004

New Doppler ultrasound signs improve diagnosis of cirrhosis or severe liver fibrosis

July 14 2004

Experts Probe Cirrhosis-Related Fatigue

July 07 2004

Cirrhosis:
An Introduction

July 01 2004

Prevention of Hepatocellular Carcinoma

July 2004

Natural History of Cirrhosis

July 2004

Page Nineteen

New treatment offers hope to hepatitis C virus sufferers

June 18 2004

Mitchell Shiffman and colleagues report results from the first 604 patients enrolled into the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) trial.

Gene therapy breakthrough

June 05 2004

Page Eighteen

New Approach for Minimal Hepatic Encephalopathy?

May 27 04

Cirrhotic nodules sometimes resemble liver cancer on computed tomography

May 27 04

Anemia Is a Major Determinant of Fatigue in Patients with Cirrhosis
May 26 2004

Texan fights cancer with new treatment-HCV, cirrhosis and cancer

May 25 2004

Page Seventeen

Actimmune for Advanced Liver Cirrhosis Fails in Phase II Study

China develops new artificial liver machine

New test detects cirrhosis

Diabetes raises risk of serious liver problems

May 25 04

Treatment Considerations in Patients with Hepatitis C and Cirrhosis `

May 04 2004

The Relationship of Chronic Viral Hepatitis, Alcoholism, and Cirrhosis to Liver Cancer

A Sustained Viral Response Predicts a Significant Decrease in Clinical Complications Among Patients with Advanced Fibrosis or Cirrhosis

Future Trends of HCV-related Cirrhosis and Hepatocellular Carcinoma in Greece after Adjusting for Access to Peginterferon and Ribavirin

April 14 2004

Page Sixteen

Impact of Pegylated Interferon alfa-2b (Peg-Intron) and Ribavirin on Progression of Liver Fibrosis in patients with Chronic Hepatitis C

Can Cirrhotics Achieve a Histologic Response?

Normalization of ALT in HCV Patients with Cirrhosis Significantly Reduces the Risk of Hepatocellular Carcinoma

Half of Cirrhosis Patients Respond to Pegasys and Ribavirin

The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club

Combining Induction and Prolonged Maintenance Therapy Produces High Sustained Virological Response in Chronic HCV Patients

HCV cirrhosis is a life threatening disease

Page Fifteen

Treatment considerations in patients with hepatitis C and cirrhosis

NUTRITIONAL SUPPLEMENTATION IN ADVANCED CIRRHOSIS.....

Pathogenesis of Hepatic Encephalopathy in Acute Liver Failure

Page Fourteen

Predicting Progression to Cirrhosis in Chronic HCV Infection

Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis

Protein markers could shed light on the origins of liver cancer

Peripheral neuropathy in liver cirrhosis.

Axcan Licenses Drug for the Treatment of Hepatic Encephalopathy from Merz Pharmaceuticals

Page Thirteen

Reversal of cirrhosis: evidence-based medicine?

Transnasal diagnostic upper gastrointestinal endoscopy appears to be a promising alternative to peroral upper endoscopy

Cirrhosis: Circulatory Changes

Advances in Endoscopy and Endoscopic Sedation

Treatment Considerations in Patients with Hepatitis C and Cirrhosis

Cirrhotic patients with spontaneous bacterial peritonitis

DO OVER-THE-COUNTER ANALGESICS CONTRIBUTE TO DECOMPENSATION OF CIRRHOSIS? - A PROSPECTIVE STUDY

Page Eleven

Treating Patients with Decompensated Cirrhosis: 20% sustained response rate

Treatment of Chronic Hepatitis C in Decompensated Cirrhotics

Pegasys News: 4 year follow-up; study of treating cirrhotics; study of Peg-Intron non-responders

	Page Ten Good news for Hepatitis C Patients with Cirrhosis
	Quantitative liver function predicts development of HCV-related cirrhosis
	Common Hepatitis C Virus Genotype Raises Cirrhotic Decompensation Risk
	New Treatment Stops Liver Scarring in Mice
	InterMune Announces Start of Phase II Trial of Actimmune for the Treatment Of Liver Fibrosis
	HCV and Estrogen in Women
	Peginterferon alfa-2a in Chronic HCV & Cirrhosis or Bridging Fibrosis
	Prevention of cirrhosis is the best measure against hepatocellular cancer Liver Scarring Not Always Permanent Study shows surgery reverses cirrhosis in some patients

Design downloaded from Zeroweb.org: Free website templates, layouts, and tools.